A new international research has suggested such mix and match of Oxford-AstraZeneca and Pfizer-BioNTech vaccines had produced a potent immune response among participants.

A new international research has suggested such mix and match of Oxford-AstraZeneca and Pfizer-BioNTech vaccines had produced a potent immune response among participants.